The higher frequency of the rs10733113 AG genotype seen in AD and the inflammatory status typical of the disease, together with post-transcriptional modification, might also explain why GNV robustly reduced the expression of NLRP3 proteins but only marginally affected that of NLRP3 mRNAs. This evidence concerns the gene NLRP3 and Alzheimer disease.